Manuj Agarwal, MD

MD:  SUNY Downstate Medical Center – College of Medicine

Internship:  Hofstra North Shore Long Island Jewish School of Medicine – Internal Medicine

Residency:  SUNY Downstate Medical Center – Radiation Oncology

Certifications:  American Board of Radiology

Dr. Agarwal is a native of New York, where he received his undergraduate and medical education, as well as residency training. He has received several academic and travel awards, including grants from the American Brachytherapy Society, New York State Assembly, and the American Association of Neurosurgical Surgeons.

Dr. Agarwal’s specializes in the treatment of cancers of the head and neck, genitourinary system, gynecologic system, skin and spine. His expertise includes the use of brachytherapy, intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT), stereotactic body radiation therapy (SBRT), and spot-scanning proton therapy for the treatment of cancer.He is recognized as a regional leader in brachytherapy and serves on national committees for the American Brachytherapy Society. He is also actively involved in enrollment on clinical trials.

Prior to medical school, Dr. Agarwal worked as a Patent Examiner for the United States Patent and Trademark Office which reflects his focus on innovation. His efforts have yielded 14 publications,20 national presentations, one patent and two pending patents. His clinical research interests concentrate on prostate and head and neck cancers, as well as the integration of complementary therapy into cancer therapy.

During his free time, Dr. Agarwal enjoys cycling, playing basketball and spending time with his wife and daughter.

1. Agarwal M, Chen S, Chhabra A, Rotman M, Schwartz D, Schreiber D. Concordance between prostate needle biopsy and Surgical Histopathology in a Primary African-American Population. Int J Surg Path. 2013;22(5): 414-19. PMID 24344156
2. Schreiber D, Rineer J, Surapaneni A, Navo E, Agarwal, M, Nwokedi E, Rotman M, Schwartz D. Dose Escalated Radiation Therapy with or without Short Course Androgen Deprivation for Intermediate Risk Prostate Cancer. Anti-Cancer Research. 2014; 34(8): 4189-93. PMID: 25075045
3. Wong AT, Schreiber D, Agarwal M, Polubarov A, Schwartz D. Impact of the Use of an Endorectal Balloon on Rectal Dosimetry during Stereotactic Body Radiation Therapy for Localized Prostate Cancer. Practical Radiation Oncology. 2016; 6(4) 262-7. PMID 26725959
4. Gamez ME, Agarwal M, Hu K, Lukens JN, Harrison LB. Hypofractionated Palliative Radiotherapy With Concurrent Chemotherapy For Advanced Head And Neck Cancer: The Quad-shot Regimen. Anticancer Research. 2017; 37(2): 685-691. PMID 2817931
5.  Amin NP, Agarwal M, Maliha Z, Simone CB. Acute Pancreatitis: An Unexpected Toxicity when Combining Nivolumab and Stereotactic Body Radiation Therapy, Practical Radiation Oncology. 2018; 8(4). 234-238. PMID 29452870.
6. Amin N, Agarwal M, Maliha Z, Mattes M. Multi-institutional Report on Toxicities of Concurrent Nivolumab and Radiation Therapy. Adv Rad Onc. 2018; 3(3). 399-404.
7. Agarwal M, Chhabra AM, Amin N, Molitaris J, Braccioforte MH, Moran BJ. Long Term Outcomes Analysis of Low Dose Rate Brachytherapy (LDR-BT) in Clinically T3 High-Risk Prostate Cancer. Brachytherapy. 2018 (in-press)
8. Decesaris C, Amin N, Vujaskovic Z, Agarwal M. Hyperthermia and Hyper-fractionated External Beam Radiation for a Cutaneous Squamous Cell Carcinoma Progressing on Standard Therapy: A Case Report. Adv Rad Onc 2018 (in-press).